{"id":15578,"date":"2026-04-20T07:39:16","date_gmt":"2026-04-20T05:39:16","guid":{"rendered":"https:\/\/www.kliinikum.ee\/yhendlabor\/?page_id=15578"},"modified":"2026-04-20T08:11:54","modified_gmt":"2026-04-20T06:11:54","slug":"neuronaalsete-antigeenide-igg-paneel-ib","status":"publish","type":"page","link":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/autoimmuunuuringud\/neuronaalsete-antigeenide-igg-paneel-ib\/","title":{"rendered":"Neuronaalsete antigeenide IgG paneel (IB)"},"content":{"rendered":"\n<p><em>Immuunanal\u00fc\u00fcsi osakond<\/em><\/p>\n\n\n\n<h4 class=\"wp-block-heading has-medium-font-size\">Anal\u00fc\u00fcsid:<\/h4>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td><\/td><td>Ri IgG<\/td><\/tr><tr><td><\/td><td>CV2 (CRMP5) IgG<\/td><\/tr><tr><td><\/td><td>Sox1 IgG<\/td><\/tr><tr><td><\/td><td>GAD65 IgG<\/td><\/tr><tr><td><\/td><td>Hu IgG&nbsp;<\/td><\/tr><tr><td><\/td><td>PNMA-2 (Ma2\/Ta) IgG<\/td><\/tr><tr><td><\/td><td>Rekoveriini IgG<\/td><\/tr><tr><td><\/td><td>Titiini IgG<\/td><\/tr><tr><td><\/td><td>Yo IgG<\/td><\/tr><tr><td><\/td><td>Amfif\u00fcsiini IgG<\/td><\/tr><tr><td><\/td><td>Zic4 IgG<\/td><\/tr><tr><td><\/td><td>Tr (DNER)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Ri<\/strong>-vastased IgG antikehad seonduvad keskn\u00e4rvis\u00fcsteemi neuronite tuumas oleva NOVA1 (Ri, 55 kDa) valguga.<\/p>\n\n\n\n<p><strong>CV2 (CRMP5)<\/strong>-vastased IgG antikehad seonduvad oligodendrots\u00fc\u00fctide ts\u00fctoplasmas oleva CRMP5 valguga.<\/p>\n\n\n\n<p><strong>Sox1<\/strong>-vastased IgG antikehad seonduvad Bergmanni gliia rakkude tuumas oleva SOX1 valguga.<\/p>\n\n\n\n<p><strong>GAD65<\/strong>-vastased IgG antikehad seonduvad v\u00e4ikeaju granulaarses kihis oleva GAD65 valguga.<\/p>\n\n\n\n<p><strong>Hu<\/strong>-vastased IgG antikehad seonduvad kesk- ja perifeerse n\u00e4rvis\u00fcsteemi neuronite tuumas olevate Hu-valkudega.<\/p>\n\n\n\n<p><strong>PNMA-2 <\/strong><strong>(Ma2\/Ta)<\/strong>-vastased IgG antikehad seonduvad neuronites ja munandites oleva PNMA2 valguga.<\/p>\n\n\n\n<p><strong>Rekoveriini<\/strong>-vastased IgG antikehad seonduvad reetina fotoretseptorites oleva rekoveriini valguga.<\/p>\n\n\n\n<p><strong>Titiini<\/strong>-vastased IgG antikehad seonduvad v\u00f6\u00f6tlihaste rakkudes oleva titiini valguga.<\/p>\n\n\n\n<p><strong>Yo<\/strong>-vastased IgG antikehad seonduvad v\u00e4ikeaju Purkinje rakkude ts\u00fctoplasmas oleva Yo-antigeeniga.<\/p>\n\n\n\n<p><strong>Amfif\u00fcsiini<\/strong>-vastased IgG antikehad seonduvad s\u00fcnaptiliste vesiikulite membraanil oleva amfif\u00fcsiin I valguga.<\/p>\n\n\n\n<p><strong>Zic4<\/strong>-vastased IgG antikehad seonduvad neuronite tuumas, peamiselt v\u00e4ikeaju granulaarses kihis, oleva Zic4 valguga.<\/p>\n\n\n\n<p><strong>Tr (DNER)<\/strong>-vastased IgG antikehad seonduvad v\u00e4ikeaju Purkinje rakkude ts\u00fctoplasmas oleva Tr-antigeeniga.<\/p>\n\n\n\n<p>Paraneoplastilisi neuroloogilisi s\u00fcndroome (PNS) seostatakse pahaloomuliste kasvajatega, kuid PNS teke ei ole otseselt p\u00f5hjustatud tuumorite, nende metastaaside, vaskulaarsete ja &nbsp;infektsioossete tegurite v\u00f5i kasvajavastase teraapia poolt. PNS-i p\u00f5hjustab kasvajaseoseline immuunvastus, mille k\u00e4igus tekib ristreaktiivsus n\u00e4rvis\u00fcsteemile iseloomulike antigeenidega. See viib neuronite ja teiste n\u00e4rvis\u00fcsteemi struktuuride kahjustusteni, avaldudes kliiniliselt sageli primaarsest v\u00f5i metastaatilisest kasvajakoldest kaugemal. PNS-i esineb ligi 15% pahaloomuliste kasvajate korral, eriti kopsu- ja soolev\u00e4hi, aga ka rinna-, munasarja- ja eesn\u00e4\u00e4rmev\u00e4hi korral. PNS v\u00f5ib ilmneda enne kasvaja diagnoosimist (60\u201380%), samaaegselt kasvaja diagnoosimisega v\u00f5i selle foonil. Samuti v\u00f5ib PNS-i esineda autoimmuunhaiguste korral (nt I t\u00fc\u00fcpi diabeet).<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Uuritav materjal, selle v\u00f5tmine, saatmine ja s\u00e4ilitamine<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table><tbody><tr><td><\/td><td>Katsuti<\/td><td>Geeli ja h\u00fc\u00fcbimisaktivaatoriga katsuti (punane kollase r\u00f5ngagav\u00f5i kollane kork)<\/td><\/tr><tr><td><\/td><td>S\u00e4ilivus<\/td><td>Seerum +4 \u00b0C 14 p\u00e4eva<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Anal\u00fc\u00fcsi tegemise aeg:<\/strong> kolm korda n\u00e4dalas<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Anal\u00fc\u00fcsimeetod:<\/strong> immunoblot-meetod (IB)<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Vastuse vorm:<\/strong> negatiivne\/positiivne<\/p>\n\n\n\n<p>IB meetodil saadud positiivne tulemus tuleb \u00fcle kinnitada teise s\u00f5ltumatu meetodiga (proovid saadetakse PERH laborisse, kus need anal\u00fc\u00fcsitakse kaudse immunofluorestsentsmeetodiga (IIF)). Kahel meetodil saadud positiivne tulemus annab l\u00f5pliku anal\u00fc\u00fcsivastuse.<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>N\u00e4idustus ja kliiniline t\u00e4hendus<\/strong><\/p>\n\n\n\n<p>Paraneoplastiliste neuroloogiliste s\u00fcndroomide diagnostika.<\/p>\n\n\n\n<p>Tabel 1. Neuroloogiliste haiguste ning kasvajate seos PNS-i autoantikehadega<strong>.<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td><\/td><td><strong>&nbsp;<\/strong><\/td><td><strong>Neuroloogilised haigused<\/strong><\/td><td><strong>Kasvajad<\/strong><\/td><\/tr><tr><td><\/td><td><strong>Ri IgG<\/strong><\/td><td>paraneoplastiline opsokloonus-m\u00fcokloonus ataksia (POMA), paraneoplastiline tserebellaarne degeneratsioon (PCD), rombentsefaliit<\/td><td>V\u00e4ikerakuline kopsuv\u00e4hk (SCLC), rinnav\u00e4hk, Hodgkini l\u00fcmfoom, mitte-Hodgkini l\u00fcmfoom, kiire kasvuga ajut\u00fcve kasvaja, munasarjav\u00e4hk<\/td><\/tr><tr><td><\/td><td><strong>CV2 (CRMP5) IgG<\/strong><strong><\/strong><\/td><td>limbiline entsefaliit, PCD, pol\u00fcneuropaatia (autonoomne, sensoorne, sensomotoorne), retinopaata, uveiit, m\u00fcasteeniline s\u00fcndroom, krooniline gastrointestinaalne pseudoobstruktsioon, koorea, POMA, rombentsefaliit, fokaalne epilepsia<\/td><td>SCLC, t\u00fcmoom, emaka sarkoom<\/td><\/tr><tr><td><\/td><td><strong>Sox1 IgG<\/strong><strong><\/strong><\/td><td>Lambert-Eatoni m\u00fcasteeniline s\u00fcndroom (LEMS), PCD<\/td><td>SCLC<\/td><\/tr><tr><td><\/td><td><strong>GAD65 IgG<\/strong><strong><\/strong><\/td><td><em>Stiff person<\/em> s\u00fcndroom (SPS). V\u00f5ib esineda koos I t\u00fc\u00fcpi diabeediga.<\/td><td>SCLC, rinnav\u00e4hk, soolev\u00e4hk<\/td><\/tr><tr><td><\/td><td><strong>Hu IgG<\/strong><strong><\/strong><\/td><td>ajut\u00fcve entsefaliidid v\u00e4ikeaju ja limbilise s\u00fcsteemi haaratusega, m\u00fceliit, pol\u00fcneuropaatia (autonoomne, sensoorne, sensomotoorne) PCD, ekstrap\u00fcramidaalsed motoorsed s\u00fcndroomid, POMA, LEMS, krooniline gastrointestinaalne pseudoobstruktsioon, retinopaatia<\/td><td>SCLC (80%), neuroblastoom, eesn\u00e4\u00e4rme, p\u00f5ie-, munasarja-, pankrease ja rinnav\u00e4hk, seedetrakti pahaloomulised kasvajad<\/td><\/tr><tr><td><\/td><td><strong>PNMA-2 IgG<\/strong><\/td><td>rombentsefaliit, PLE, ajut\u00fcve entsefalopaatia, POMA, PCD, ekstrap\u00fcramidaalsed motoorsed s\u00fcndroomid, retinopaata<\/td><td>munandi idurakuline kartsinoom (seminoom), mittev\u00e4ikerakuline kopsuv\u00e4hk, s\u00fcljen\u00e4\u00e4rme, rinna-, munasarja, j\u00e4mesoole ja neeruv\u00e4hk, l\u00fcmfoom<\/td><\/tr><tr><td><\/td><td><strong>Rekoveriini IgG<\/strong><strong><\/strong><\/td><td>retinopaatia<\/td><td>SCLC<\/td><\/tr><tr><td><\/td><td><strong>Titiini IgG<\/strong><strong><\/strong><\/td><td><em>Myasthenia gravis<\/em><\/td><td>t\u00fcmoom<\/td><\/tr><tr><td><\/td><td><strong>Yo IgG<\/strong><strong><\/strong><\/td><td>PCD, POMA<\/td><td>munasarja-, rinna-, emakav\u00e4hk, s\u00f6\u00f6gitoru adenokartsinoom, sapip\u00f5ie, eesn\u00e4\u00e4rme v\u00e4hk, Hodgkini l\u00fcmfoom, mitte-Hodgkini l\u00fcmfoom, t\u00fcmoom<\/td><\/tr><tr><td><\/td><td><strong>Amfif\u00fcsiini IgG<\/strong><strong><\/strong><\/td><td><em>Stiff person<\/em> s\u00fcndroom (SPS), m\u00fcasteeniline s\u00fcndroom, pol\u00fcneuropaatia (autonoomne, sensoorne, sensomotoorne), rigiidsusega kulgev entsefalom\u00fceliit, tserebellaarne ataksia, POMA<\/td><td>rinnav\u00e4hk, SCLC, t\u00fcmoom, Hodgkini l\u00fcmfoom, j\u00e4mesoolev\u00e4hk<\/td><\/tr><tr><td><\/td><td><strong>Zic4 IgG<\/strong><strong><\/strong><\/td><td>tserebellaarne degeneratsioon<\/td><td>SCLC<\/td><\/tr><tr><td><\/td><td><strong>Tr(DNER) IgG<\/strong><\/td><td>tserebellaarne degeneratsioon, harva limbiline enstefaliit, entsefalopaatia, sensoorne neuropaatia<\/td><td>Hodgkini l\u00fcmfoom<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>Neuronaalsete antigeenide IgG paneel (IB) ei ole sobilik GAD65-vastaste antikehade anal\u00fc\u00fcsimiseks diabeedi korral. Negatiivne tulemus neuronaalsete antigeenide IgG paneelil ei v\u00e4lista anti-GAD65 olemasolu.<\/p>\n\n\n\n<p>Vt ka Autoimmuunse diabeedi uuringud<\/p>\n\n\n\n<p>Koostajad: Anet Laanesoo, Ija Talja<\/p>\n\n\n\n<p>Koostatud: 17.04.2026<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Immuunanal\u00fc\u00fcsi osakond Anal\u00fc\u00fcsid: Ri IgG CV2 (CRMP5) IgG Sox1 IgG GAD65 IgG Hu IgG&nbsp; PNMA-2 (Ma2\/Ta) IgG Rekoveriini IgG Titiini IgG Yo IgG Amfif\u00fcsiini IgG Zic4 IgG Tr (DNER) Ri-vastased IgG antikehad seonduvad keskn\u00e4rvis\u00fcsteemi neuronite tuumas oleva NOVA1 (Ri, 55 kDa) valguga. CV2 (CRMP5)-vastased IgG antikehad seonduvad oligodendrots\u00fc\u00fctide ts\u00fctoplasmas oleva CRMP5 valguga. Sox1-vastased IgG antikehad [&hellip;]<\/p>\n","protected":false},"author":31,"featured_media":0,"parent":7253,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_uag_custom_page_level_css":"","footnotes":""},"class_list":["post-15578","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Neuronaalsete antigeenide IgG paneel (IB) - \u00dchendlabor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/autoimmuunuuringud\/neuronaalsete-antigeenide-igg-paneel-ib\/\" \/>\n<meta property=\"og:locale\" content=\"et_EE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neuronaalsete antigeenide IgG paneel (IB) - \u00dchendlabor\" \/>\n<meta property=\"og:description\" content=\"Immuunanal\u00fc\u00fcsi osakond Anal\u00fc\u00fcsid: Ri IgG CV2 (CRMP5) IgG Sox1 IgG GAD65 IgG Hu IgG&nbsp; PNMA-2 (Ma2\/Ta) IgG Rekoveriini IgG Titiini IgG Yo IgG Amfif\u00fcsiini IgG Zic4 IgG Tr (DNER) Ri-vastased IgG antikehad seonduvad keskn\u00e4rvis\u00fcsteemi neuronite tuumas oleva NOVA1 (Ri, 55 kDa) valguga. CV2 (CRMP5)-vastased IgG antikehad seonduvad oligodendrots\u00fc\u00fctide ts\u00fctoplasmas oleva CRMP5 valguga. Sox1-vastased IgG antikehad [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/autoimmuunuuringud\/neuronaalsete-antigeenide-igg-paneel-ib\/\" \/>\n<meta property=\"og:site_name\" content=\"\u00dchendlabor\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-20T06:11:54+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/autoimmuunuuringud\\\/neuronaalsete-antigeenide-igg-paneel-ib\\\/\",\"url\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/autoimmuunuuringud\\\/neuronaalsete-antigeenide-igg-paneel-ib\\\/\",\"name\":\"Neuronaalsete antigeenide IgG paneel (IB) - \u00dchendlabor\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/#website\"},\"datePublished\":\"2026-04-20T05:39:16+00:00\",\"dateModified\":\"2026-04-20T06:11:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/autoimmuunuuringud\\\/neuronaalsete-antigeenide-igg-paneel-ib\\\/#breadcrumb\"},\"inLanguage\":\"et\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/autoimmuunuuringud\\\/neuronaalsete-antigeenide-igg-paneel-ib\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/autoimmuunuuringud\\\/neuronaalsete-antigeenide-igg-paneel-ib\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"K\u00e4siraamat\",\"item\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Autoimmuunuuringud\",\"item\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/autoimmuunuuringud\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Neuronaalsete antigeenide IgG paneel (IB)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/#website\",\"url\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/\",\"name\":\"\u00dchendlabor\",\"description\":\"Hoolivus, Uuendusmeelsus, P\u00e4devus ja Usaldusv\u00e4\u00e4rsus\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"et\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neuronaalsete antigeenide IgG paneel (IB) - \u00dchendlabor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/autoimmuunuuringud\/neuronaalsete-antigeenide-igg-paneel-ib\/","og_locale":"et_EE","og_type":"article","og_title":"Neuronaalsete antigeenide IgG paneel (IB) - \u00dchendlabor","og_description":"Immuunanal\u00fc\u00fcsi osakond Anal\u00fc\u00fcsid: Ri IgG CV2 (CRMP5) IgG Sox1 IgG GAD65 IgG Hu IgG&nbsp; PNMA-2 (Ma2\/Ta) IgG Rekoveriini IgG Titiini IgG Yo IgG Amfif\u00fcsiini IgG Zic4 IgG Tr (DNER) Ri-vastased IgG antikehad seonduvad keskn\u00e4rvis\u00fcsteemi neuronite tuumas oleva NOVA1 (Ri, 55 kDa) valguga. CV2 (CRMP5)-vastased IgG antikehad seonduvad oligodendrots\u00fc\u00fctide ts\u00fctoplasmas oleva CRMP5 valguga. Sox1-vastased IgG antikehad [&hellip;]","og_url":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/autoimmuunuuringud\/neuronaalsete-antigeenide-igg-paneel-ib\/","og_site_name":"\u00dchendlabor","article_modified_time":"2026-04-20T06:11:54+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/autoimmuunuuringud\/neuronaalsete-antigeenide-igg-paneel-ib\/","url":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/autoimmuunuuringud\/neuronaalsete-antigeenide-igg-paneel-ib\/","name":"Neuronaalsete antigeenide IgG paneel (IB) - \u00dchendlabor","isPartOf":{"@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/#website"},"datePublished":"2026-04-20T05:39:16+00:00","dateModified":"2026-04-20T06:11:54+00:00","breadcrumb":{"@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/autoimmuunuuringud\/neuronaalsete-antigeenide-igg-paneel-ib\/#breadcrumb"},"inLanguage":"et","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/autoimmuunuuringud\/neuronaalsete-antigeenide-igg-paneel-ib\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/autoimmuunuuringud\/neuronaalsete-antigeenide-igg-paneel-ib\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.kliinikum.ee\/yhendlabor\/"},{"@type":"ListItem","position":2,"name":"K\u00e4siraamat","item":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/"},{"@type":"ListItem","position":3,"name":"Autoimmuunuuringud","item":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/autoimmuunuuringud\/"},{"@type":"ListItem","position":4,"name":"Neuronaalsete antigeenide IgG paneel (IB)"}]},{"@type":"WebSite","@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/#website","url":"https:\/\/www.kliinikum.ee\/yhendlabor\/","name":"\u00dchendlabor","description":"Hoolivus, Uuendusmeelsus, P\u00e4devus ja Usaldusv\u00e4\u00e4rsus","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.kliinikum.ee\/yhendlabor\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"et"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false},"uagb_author_info":{"display_name":"Kaja Vaagen","author_link":"https:\/\/www.kliinikum.ee\/yhendlabor\/author\/kajakall\/"},"uagb_comment_info":0,"uagb_excerpt":"Immuunanal\u00fc\u00fcsi osakond Anal\u00fc\u00fcsid: Ri IgG CV2 (CRMP5) IgG Sox1 IgG GAD65 IgG Hu IgG&nbsp; PNMA-2 (Ma2\/Ta) IgG Rekoveriini IgG Titiini IgG Yo IgG Amfif\u00fcsiini IgG Zic4 IgG Tr (DNER) Ri-vastased IgG antikehad seonduvad keskn\u00e4rvis\u00fcsteemi neuronite tuumas oleva NOVA1 (Ri, 55 kDa) valguga. CV2 (CRMP5)-vastased IgG antikehad seonduvad oligodendrots\u00fc\u00fctide ts\u00fctoplasmas oleva CRMP5 valguga. Sox1-vastased IgG antikehad&hellip;","_links":{"self":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages\/15578","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/users\/31"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/comments?post=15578"}],"version-history":[{"count":3,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages\/15578\/revisions"}],"predecessor-version":[{"id":15586,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages\/15578\/revisions\/15586"}],"up":[{"embeddable":true,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages\/7253"}],"wp:attachment":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/media?parent=15578"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}